Skip to content
Pompe Disease News logo
  • About Pompe
    What is Pompe disease?
    Types
    Symptoms
    Causes
    Diagnosis
    Treatment options
    • Lumizyme
    • Nexviazyme
    • Pombiliti + Opfolda
  • News
  • Columns
    The Pompe Community Diaries – Anthony Wu
    Powering Through Pompe — Keara Engle
    Archived columns
    • On the Road to Pompe — Dwayne Wilson
  • Living with Pompe
    Adaptive clothing
    Living with Pompe disease
    ERT and enzyme stabilizers
    The ERT process
    Your daily routine with LOPD
    Adaptive equipment
    Late-onset Pompe disease
    Dwayne’s story
    Expert voice: Safe and effective exercise
    How is Pompe disease inherited?
    Pompe disease and diet
    Reproductive options
    Support groups and resources
    LOPD and respiratory health
    Mental health
    Pompe and fatigue
    Travel and LOPD
    Exercise and physical therapy
    Science behind treatment
    ERT challenges
    Navigating school and work
    Pompe prevalence
    Pompe disease progression
  • Pompe pathways
    ERT home infusions
    Therapeutic crossroads
    Tips for caregivers
    Maximizing doctor’s appointments
    Building an LOPD care team
    Financial planning with Pompe
    Work and Pompe
    Occupational therapy
    Pompe and pain
  • FAQs
  • Advocacy partners
  • What can we help you find today?

April 17, 2025 News by Lindsey Shapiro, PhD

Genomic medicine corrects common LOPD defect in cells, mice

A genomic medicine designed to correct the genetic defect found in up to 90% of people with late-onset Pompe disease (LOPD) worked as intended in patient-derived muscle cells and a mouse model, according to a study. The study, “Splicing correction by peptide-conjugated morpholinos as a novel…

June 20, 2018 News by Marta Figueiredo, PhD

Gene Therapy Using Improved Virus Holds Promise for Pompe Disease Treatment, Mouse Study Shows

Gene therapy, using an improved version of a virus as a delivery vehicle, greatly improved muscle and respiratory function in a mouse model of Pompe disease. The study, “Systemic delivery of AAVB1-GAA clears glycogen and prolongs survival in a mouse model of Pompe disease,” was published in…

Recent Posts

  • Gene, enzyme replacement improve mice’s breathing, limb strength
  • Short-distance walking speed test in Pompe disease is less demanding
  • Nervous system involvement is common in Pompe disease: Study


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.